These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23180261)

  • 1. New Zealand's regulation of cosmetic products containing nanomaterials.
    Moore J
    J Bioeth Inq; 2012 Jun; 9(2):185-8. PubMed ID: 23180261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology in cosmetics.
    Katz LM; Dewan K; Bronaugh RL
    Food Chem Toxicol; 2015 Nov; 85():127-37. PubMed ID: 26159063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk management by labelling 26 fragrances? Evaluation of Article 10 (1) of the seventh Amendment (Guideline 2003/15/EC) of the Cosmetic Directive.
    Klaschka U
    Int J Hyg Environ Health; 2010 Jul; 213(4):308-20. PubMed ID: 20451450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is New Zealand's regulation of nanomedical products adequate?
    Moore J
    J Law Med; 2011 Sep; 19(1):112-27. PubMed ID: 21988014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed changes to New Zealand's medicines legislation in the Medicines Amendment Bill 2011.
    Moore J
    J Bioeth Inq; 2013 Mar; 10(1):59-66. PubMed ID: 23283819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expected change of direction in Polish law regarding cosmetics].
    Karłowski K; Smietanka B; Biernat U; Burzyńska I; Pawłowska K
    Rocz Panstw Zakl Hig; 2004; 55(1):21-5. PubMed ID: 15307612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SCCS scientific advice on the safety of nanomaterials in cosmetics.
    ; Bernauer U; Bodin L; Chaudhry Q; Coenraads PJ; Dusinska M; Gaffet E; Panteri E; Rogiers V; Rousselle C; Stepnik M; Vanhaecke T; Wijnhoven S; ; von Goetz N; de Jong WH
    Regul Toxicol Pharmacol; 2021 Nov; 126():105046. PubMed ID: 34560169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosmetic Regulations: A Comparative Study.
    Suhag J; Dureja H
    Skinmed; 2015; 13(3):191-4. PubMed ID: 26380505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?
    Musazzi UM; Marini V; Casiraghi A; Minghetti P
    Drug Discov Today; 2017 Jun; 22(6):870-882. PubMed ID: 28189800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of nanomaterials in cosmetics: a European union perspective.
    Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
    Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold Nanomaterials in Consumer Cosmetics Nanoproducts: Analyses, Characterization, and Dermal Safety Assessment.
    Cao M; Li J; Tang J; Chen C; Zhao Y
    Small; 2016 Oct; 12(39):5488-5496. PubMed ID: 27562146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction.
    Termini RB; Tressler L
    Food Drug Law J; 2008; 63(1):257-74. PubMed ID: 18561461
    [No Abstract]   [Full Text] [Related]  

  • 13. Is it time to revise CFR title 21-Food Drugs & Cosmetics Act for skin care products?
    Epstein HA
    Skinmed; 2013; 11(5):297-9. PubMed ID: 24340471
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nanomaterials in cosmetics--present situation and future].
    Masunaga T
    Yakugaku Zasshi; 2014; 134(1):39-43. PubMed ID: 24389615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SCCS guidance on the safety assessment of nanomaterials in cosmetics.
    ; ;
    Regul Toxicol Pharmacol; 2020 Apr; 112():104611. PubMed ID: 32061657
    [No Abstract]   [Full Text] [Related]  

  • 17. Myths, beliefs and fragrance allergy.
    Contact Dermatitis; 2013 Oct; 69(4):193-5. PubMed ID: 24028782
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced Dark-Field Hyperspectral Imaging and Spectral Angle Mapping for Nanomaterial Detection in Consumer Care Products and in Skin Following Dermal Exposure.
    Boyadzhiev A; Trevithick-Sutton C; Wu D; Decan N; Bazin M; Shah GM; Halappanavar S
    Chem Res Toxicol; 2020 May; 33(5):1266-1278. PubMed ID: 32338506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cosmetic products : Safety aspects].
    Platzek T; Krätke R; Schulz C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):610-4. PubMed ID: 20464352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cosmetic products and their current European regulatory framework.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.